Literature DB >> 3397061

Molecular cloning of the mouse angiotensinogen gene.

W M Clouston1, B A Evans, J Haralambidis, R I Richards.   

Abstract

We describe here the cloning, restriction mapping, and sequencing of the mouse angiotensinogen gene. The 5' flanking region contains consensus sequences for several hormone-responsive elements and viral-like enhancers within 750 bp of the cap site. The deduced amino acid sequence shows 87% identity with rat angiotensinogen, but there is a discrepancy in the number of cysteine residues in the mature protein among rat (n = 3), human (n = 4), and mouse (n = 4). Because angiotensinogen is homologous to other members of the serine protease inhibitor family, we aligned the putative reactive center of angiotensinogens from various species. This alignment shows that the inhibitor site in human angiotensinogen is different from its rodent counterpart, but the role of this sequence divergence in the pathogenesis of human disease remains to be established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397061     DOI: 10.1016/0888-7543(88)90008-0

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  17 in total

1.  An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene.

Authors:  D Ron; A R Brasier; K A Wright; J E Tate; J F Habener
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

2.  Adult stage gamma-globin silencing is mediated by a promoter direct repeat element.

Authors:  Akane Omori; Osamu Tanabe; James Douglas Engel; Akiyoshi Fukamizu; Keiji Tanimoto
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

3.  Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation.

Authors:  F Niimura; P A Labosky; J Kakuchi; S Okubo; H Yoshida; T Oikawa; T Ichiki; A J Naftilan; A Fogo; T Inagami
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  An allelic polymorphism of the angiotensinogen gene in mice.

Authors:  W M Clouston; R I Richards
Journal:  Nucleic Acids Res       Date:  1989-01-25       Impact factor: 16.971

5.  Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration.

Authors:  Hyung-Suk Kim; Gene Lee; Simon W M John; Nobuyo Maeda; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

6.  Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review.

Authors:  Congqing Wu; Hong Lu; Lisa A Cassis; Alan Daugherty
Journal:  N Am J Med Sci (Boston)       Date:  2011-10-01

7.  Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice.

Authors:  O Smithies; H S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Genetic control of blood pressure and the angiotensinogen locus.

Authors:  H S Kim; J H Krege; K D Kluckman; J R Hagaman; J B Hodgin; C F Best; J C Jennette; T M Coffman; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  All of the human beta-type globin genes compete for LCR enhancer activity in embryonic erythroid cells of yeast artificial chromosome transgenic mice.

Authors:  Eiichi Okamura; Hitomi Matsuzaki; Andrew D Campbell; James Douglas Engel; Akiyoshi Fukamizu; Keiji Tanimoto
Journal:  FASEB J       Date:  2009-08-18       Impact factor: 5.191

10.  Linkage of Agt and Actsk-1 to distal mouse chromosome 8 loci: a new conserved linkage.

Authors:  J P Abonia; K J Abel; R L Eddy; R W Elliott; V M Chapman; T B Shows; K W Gross
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.